IGSF9 and breast carcinoma: In GSE16446 database, we found that low IGSF9 expression in breast cancer patients was associated with worse relapse free survival (RFS) (P = 0.037) and overall survival (OS) (P = 0.019), compared with those of high IGSF9 expression (Fig. 2H, I).